| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.34 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.3 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |